Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Unknown 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 3Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3Advanced Solid Tumors 1

Interventions

Cisplatin 3199Cyclophosphamide 3193Carboplatin 2973Radiotherapy 2786Paclitaxel 2717Gemcitabine 2572pembrolizumab 2382Bevacizumab 2208Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1604Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1385Etoposide 1345Irinotecan 1248Leucovorin 1225Drug Therapy 1204Cytarabine 1130Pemetrexed 1074fludarabine 1061Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
SKLB1028 × Clear all
NCT04716114 2021-11-02

ALIVE

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Unknown
315 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05072522 2021-10-11

A Study of SKLB1028 in Patients With Advanced Solid Tumor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
98 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT04015024 2019-07-16

A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 2 Unknown
30 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02859948 2016-08-09

A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
18 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡